We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.6B
AUM Growth
+$129M
Cap. Flow
+$58.7M
Cap. Flow %
3.67%
Top 10 Hldgs %
25.88%
Holding
122
New
4
Increased
17
Reduced
39
Closed
1

Top Buys

Rank Stock Value
1
CAG icon
Conagra Brands
CAG
+$29.8M
2
GS icon
Goldman Sachs
GS
+$19.9M
3
WFC icon
Wells Fargo
WFC
+$16.5M
4
ABBV icon
AbbVie
ABBV
+$15.2M
5
TFC icon
Truist Financial
TFC
+$14.5M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$23.7M
2
QCOM icon
Qualcomm
QCOM
+$20.1M
3
CVS icon
CVS Health
CVS
+$17.6M
4
VLO icon
Valero Energy
VLO
+$17M
5
ET icon
Energy Transfer Partners
ET
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 16.14%
2 Financials 14.05%
3 Real Estate 11.18%
4 Energy 10.09%
5 Consumer Staples 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DE icon
101
Deere & Co
DE
$170B
$87K 0.01%
500
– –
LYB icon
102
LyondellBasell Industries
LYB
$19.5B
$85K 0.01%
900
– –
PG icon
103
Procter & Gamble
PG
$343B
$85K 0.01%
680
– –
NVS icon
104
Novartis
NVS
$295B
$83K 0.01%
876
– –
ORCL icon
105
Oracle
ORCL
$331B
$79K ﹤0.01%
1,500
– –
LHX icon
106
L3Harris
LHX
$55.9B
$77K ﹤0.01%
390
– –
SRCL
107
DELISTED
Stericycle Inc
SRCL
$77K ﹤0.01%
1,200
– –
ITW icon
108
Illinois Tool Works
ITW
$81.4B
$72K ﹤0.01%
400
– –
J icon
109
Jacobs Solutions
J
$15.9B
$63K ﹤0.01%
846
– –
KMB icon
110
Kimberly-Clark
KMB
$36.4B
$55K ﹤0.01%
400
– –
CL icon
111
Colgate-Palmolive
CL
$72.6B
$41K ﹤0.01%
600
– –
EEM icon
112
iShares MSCI Emerging Markets ETF
EEM
$28B
$40K ﹤0.01%
900
– –
GE icon
113
GE Aerospace
GE
$367B
$39K ﹤0.01%
703
– –
ITT icon
114
ITT
ITT
$17.5B
$30K ﹤0.01%
400
– –
DVN icon
115
Devon Energy
DVN
$51.9B
$21K ﹤0.01%
800
– –
COP icon
116
ConocoPhillips
COP
$147B
$20K ﹤0.01%
300
– –
FTV icon
117
Fortive
FTV
$19B
$20K ﹤0.01%
420
– –
BP icon
118
BP
BP
$113B
$17K ﹤0.01%
459
– –
ALC icon
119
Alcon
ALC
$33.1B
$10K ﹤0.01%
175
– –
XOM icon
120
ExxonMobil
XOM
$651B
– –
-856
Closed -$60K
1 2 3 4
5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q4 2019 Portfolio in Review

As of Q4 2019, Payden & Rygel held 122 positions worth $1.6B, up 8.8% from $1.47B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Payden & Rygel deployed $58.7M of net new capital in Q4 2019, opening 4 new positions and adding to 17 existing holdings. Its largest new stake was Conagra Brands: 1,027,000 shares worth $35.2M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Financials and Real Estate.

On the sell side, the largest reduction was Philip Morris, an estimated $23.7M trimmed.

  • Payden & Rygel's largest Q4 2019 buy was Conagra Brands: 1,027,000 shares worth $35.2M.
  • Payden & Rygel added most to Goldman Sachs in Q4 2019, an estimated $19.9M increase.
  • Payden & Rygel's biggest Q4 2019 reduction was Philip Morris, cutting an estimated $23.7M.
  • Payden & Rygel fully exited ExxonMobil in Q4 2019, selling an estimated $60K.
  • Payden & Rygel's ten largest holdings make up 26% of its $1.6B portfolio in Q4 2019.
  • Payden & Rygel opened 4 new positions and closed 1 in Q4 2019.
  • Payden & Rygel's portfolio value rose 8.8% quarter-over-quarter to $1.6B.

Based on Payden & Rygel's 13F filing for Q4 2019, filed 31 Jan 2020.